123 related articles for article (PubMed ID: 18006845)
21. Is coulomb explosion a damaging mechanism for (125)IUdR?
Pomplun E; Sutmann G
Int J Radiat Biol; 2004; 80(11-12):855-60. PubMed ID: 15764393
[TBL] [Abstract][Full Text] [Related]
22. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
[TBL] [Abstract][Full Text] [Related]
23. Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver.
Zager JS; Delman KA; Ebright MI; Malhotra S; Larson S; Fong Y
Br J Surg; 2003 Oct; 90(10):1225-31. PubMed ID: 14515291
[TBL] [Abstract][Full Text] [Related]
24. Cadmium inhibits human DNA mismatch repair in vivo.
Lützen A; Liberti SE; Rasmussen LJ
Biochem Biophys Res Commun; 2004 Aug; 321(1):21-5. PubMed ID: 15358209
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
26. BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.
Stoklosa T; Poplawski T; Koptyra M; Nieborowska-Skorska M; Basak G; Slupianek A; Rayevskaya M; Seferynska I; Herrera L; Blasiak J; Skorski T
Cancer Res; 2008 Apr; 68(8):2576-80. PubMed ID: 18413724
[TBL] [Abstract][Full Text] [Related]
27. An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
Kinsella TJ; Kunugi KA; Vielhuber KA; McCulloch W; Liu SH; Cheng YC
Cancer Res; 1994 May; 54(10):2695-700. PubMed ID: 8168099
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.
Kinsella TJ; Kunugi KA; Vielhuber KA; Potter DM; Fitzsimmons ME; Collins JM
Clin Cancer Res; 1998 Jan; 4(1):99-109. PubMed ID: 9516958
[TBL] [Abstract][Full Text] [Related]
29. 5-Fluorouracil is efficiently removed from DNA by the base excision and mismatch repair systems.
Fischer F; Baerenfaller K; Jiricny J
Gastroenterology; 2007 Dec; 133(6):1858-68. PubMed ID: 18054558
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of DNA synthesis produced by herpesvirus-transformed cell lines.
Beneke J; Pearson GR
J Immunol; 1980 Jun; 124(6):2944-9. PubMed ID: 6445386
[TBL] [Abstract][Full Text] [Related]
31. Combined effects of radiation and IUdR on experimental liver tumors and hepatocytes.
Ono K; Fushiki M; Nagata Y; Tsutsui K; Sasai K; Takahashi M; Abe M
Strahlenther Onkol; 1989 Sep; 165(9):688-92. PubMed ID: 2799631
[TBL] [Abstract][Full Text] [Related]
32. The incorporation of 5-iodo-2'-deoxyuridine into the DNA of HeLa cells and the induction of alkaline phosphatase activity.
Goz B; Walker KP
Cancer Res; 1976 Dec; 36(12):4480-5. PubMed ID: 1000496
[TBL] [Abstract][Full Text] [Related]
33. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
34. Optimal photon energies for IUdR K-edge radiosensitization with filtered x-ray and radioisotope sources.
Karnas SJ; Yu E; McGarry RC; Battista JJ
Phys Med Biol; 1999 Oct; 44(10):2537-49. PubMed ID: 10533927
[TBL] [Abstract][Full Text] [Related]
35. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors.
Munday JS; French AF; Gibson IR; Gwynne K
Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633
[TBL] [Abstract][Full Text] [Related]
36. The clinical rationale for S-phase radiosensitization in human tumors.
McGinn CJ; Kinsella TJ
Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
[TBL] [Abstract][Full Text] [Related]
37. A balanced deoxyribonucleoside mixture increased the rate of DNA incorporation of 5-[125I]Iodo-2'-deoxyuridine in glioblastoma cells.
Dupertuis YM; Buchegger F; Pichard C
Cancer Biother Radiopharm; 2003 Feb; 18(1):7-16. PubMed ID: 12667304
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the "mismatch repairosome" and its role in the processing of modified nucleosides in vitro.
Baerenfaller K; Fischer F; Jiricny J
Methods Enzymol; 2006; 408():285-303. PubMed ID: 16793376
[TBL] [Abstract][Full Text] [Related]
39. Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts.
Kinsella TJ; Vielhuber KA; Kunugi KA; Schupp J; Davis TW; Sands H
Clin Cancer Res; 2000 Apr; 6(4):1468-75. PubMed ID: 10778979
[TBL] [Abstract][Full Text] [Related]
40. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ.
Iliakis G; Wu W; Wang M
Int J Hyperthermia; 2008 Feb; 24(1):17-29. PubMed ID: 18214766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
